Mindray Medical International (NYSE: MR) reported earnings on Feb. 25. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Mindray Medical International beat expectations on revenues and crushed expectations on earnings per share.

Compared to the prior-year quarter, revenue grew significantly. Non-GAAP earnings per share increased significantly. GAAP earnings per share increased significantly.

Gross margins increased, operating margins grew, net margins were steady.

Revenue details
Mindray Medical International logged revenue of $316.1 million. The six analysts polled by S&P Capital IQ expected revenue of $307.2 million on the same basis. GAAP reported sales were 20% higher than the prior-year quarter's $264.1 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.51. The three earnings estimates compiled by S&P Capital IQ averaged $0.39 per share. Non-GAAP EPS of $0.51 for Q4 were 16% higher than the prior-year quarter's $0.44 per share. GAAP EPS of $0.47 for Q4 were 18% higher than the prior-year quarter's $0.40 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 57.8%, 360 basis points better than the prior-year quarter. Operating margin was 18.9%, 80 basis points better than the prior-year quarter. Net margin was 17.7%, much about the same as the prior-year quarter.

Looking ahead

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 1,347 members out of 1,381 rating the stock outperform, and 34 members rating it underperform. Among 285 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 273 give Mindray Medical International a green thumbs-up, and 12 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Mindray Medical International is outperform, with an average price target of $36.43.

Is Mindray Medical International the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.